AI assistant
Biocon Ltd. — Capital/Financing Update 2024
Dec 30, 2024
61176_rns_2024-12-30_ca85faa5-7d88-4d4c-9f19-1f1a8d25c4bb.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [132 x 52] intentionally omitted <==
Biocon Limited 20th KM, Hosur Road Electronic City Bangalore 560 100, India T 91 80 2808 2808 F 91 80 2852 3423 CIN : L24234KA1978PLC003417
BIO/SECL/SG/2024-25/146
December 30, 2024
To To The Manager, The Manager, BSE Limited National Stock Exchange of India Limited Department of Corporate Services Corporate Communication Department Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai – 400 001 Mumbai – 400 050 Scrip Code - 532523 Scrip Symbol - BIOCON
Subject: Notification to Stock Exchanges
Dear Sir/Madam,
Please find below a notification.
“Biocon Biologics has fulfilled its obligations towards all deferred milestones under the acquisition agreement with Viatris. This also marks, as full and final remittance of considerations from Biocon Biologics toward Viatris for the acquisition.”
The above information will also be available on the website of the Company at www.biocon.com.
Kindly take the same on record and acknowledge.
Thanking You,
Yours faithfully,
For Biocon Limited
MAYANK Digitally signed by MAYANK VERMA VERMA Date: 2024.12.30 08:59:09 +05'30'
Mayank Verma Company Secretary and Compliance Officer Membership No.: ACS 18776